Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Limulus amebocyte lysate assay

V A Spagna, R B Prior

    American Family Physician
    |September 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    The Limulus amebocyte lysate (LAL) assay is a highly sensitive test for detecting bacterial endotoxins and pyrogens in pharmaceuticals. While its use in diagnosing gram-negative infections is debated, physicians can use it as a supplementary tool in specific clinical scenarios.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Recombinant bactericidal/permeability-increasing protein (rBPI21) for treatment of parvovirus enteritis: a randomized, double-blinded, placebo-controlled trial.

    Journal of veterinary internal medicine·2001
    Same author

    Adult respiratory distress syndrome associated with epidural fentanyl infusion.

    Critical care medicine·1994
    Same author

    The Limulus amoebocyte lysate assay for prediction of chlamydial infection in males with non-gonococcal urethritis: an evaluation.

    Medical laboratory sciences·1991
    Same author

    Autosomal recessive polycystic kidney disease: characterization of human peritoneal and cystic kidney cells in vitro.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·1990
    Same author

    Detection of endotoxiuria in polycystic kidney disease patients by the use of the Limulus amebocyte lysate assay.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·1990
    Same author

    Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.

    Antimicrobial agents and chemotherapy·1989

    Area of Science:

    • Biochemistry
    • Microbiology
    • Clinical Diagnostics

    Background:

    • The Limulus amebocyte lysate (LAL) assay is the gold standard for detecting bacterial endotoxins.
    • Endotoxins are pyrogenic substances from Gram-negative bacteria, posing risks in pharmaceutical products and clinical settings.
    • The sensitivity and specificity of the LAL assay are critical for ensuring product safety and patient health.

    Purpose of the Study:

    • To highlight the established role of the LAL assay in pharmaceutical quality control.
    • To discuss the controversial yet potential utility of the LAL assay in clinical diagnostics for Gram-negative infections.
    • To provide guidance on the appropriate application of the LAL assay in medical practice.

    Main Methods:

    • Review of existing literature on the LAL assay's applications and limitations.

    Related Experiment Videos

  • Analysis of the biochemical basis of endotoxin detection using amebocyte lysate.
  • Case study considerations for LAL assay implementation in clinical settings.

    • Main Results:

    • The LAL assay demonstrates unparalleled sensitivity for endotoxin detection, making it the official pyrogen test for pharmaceuticals.
    • Evidence suggests the LAL assay's value as an adjunct diagnostic tool in specific Gram-negative infections is under investigation.
    • Clinical utility is contingent on careful selection of cases and integration with standard diagnostic procedures.

    Conclusions:

    • The LAL assay remains indispensable for pharmaceutical safety due to its high sensitivity to bacterial endotoxins.
    • Physicians may consider the LAL assay as a supplementary diagnostic method in select clinical situations involving suspected Gram-negative infections.
    • Further research is warranted to fully elucidate and validate the clinical diagnostic applications of the LAL assay beyond its established role in pyrogen testing.